94 related articles for article (PubMed ID: 12485510)
1. [Optimum mode of interventional treatment for hepatocellular carcinoma].
Chen X; Luo P; Lin H; Shao P; Zhou Z; Fu L
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):501-3. PubMed ID: 12485510
[TBL] [Abstract][Full Text] [Related]
2. [Transarterial oil chemoembolization for hepatocellular carcinoma, in 100 cases].
Levy I; Verstandig A; Sasson T; Wolf D; Krichon I; Libson E; Levensart P; Papo O; Yurim O; Id A; Shouval D
Harefuah; 2000 Jan; 138(2):89-93, 174. PubMed ID: 10883065
[TBL] [Abstract][Full Text] [Related]
3. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
4. [Long-term results of chemoembolization for hepatocarcinoma].
Feltrin GP; Savastano S; Marangon A; Miotto D; Chiesura-Corona M
Radiol Med; 1997; 94(1-2):24-9. PubMed ID: 9424646
[TBL] [Abstract][Full Text] [Related]
5. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic imaging and interventional therapy in hepatocarcinoma. Multicenter study of 290 cases].
Dalla Palma L; Pozzi Mucelli R; Sponza M; Bartolozzi C; Lencioni R; Florio F; De Santis M; Gandini G; Matricardi L; Rossi C; Simonetti G; Pocek M
Radiol Med; 1997; 94(1-2):30-6. PubMed ID: 9424647
[TBL] [Abstract][Full Text] [Related]
7. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
8. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
[TBL] [Abstract][Full Text] [Related]
9. Caffeine clearance in patients with hepatocellular carcinoma after transcatheter oily chemoembolization treatment.
Thong-Ngam D; Thumvijit L; Tangkijvanich P; Janchai A; Mahachai V; Wittayalertpanya S
J Med Assoc Thai; 2002 Dec; 85(12):1280-7. PubMed ID: 12678165
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic interventional radiology procedures in hepatocellular carcinoma].
Huppert PE; Viebahn R; Duda SH; Lauchart W
Zentralbl Chir; 1994; 119(11):787-93. PubMed ID: 7531377
[TBL] [Abstract][Full Text] [Related]
11. [Transarterial oily chemoembolization combined with interstitial laser thermotherapy for treatment of hepatocellular carcinoma].
Zhou ZJ; Xu RD; Li WK; Zhuang WX; Lu LG; Shao PJ; Chen XM; Luo PF
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1866-8. PubMed ID: 18159005
[TBL] [Abstract][Full Text] [Related]
12. Interventional treatments for hepatocellular carcinoma.
Guan YS; Liu Y
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):495-500. PubMed ID: 17085331
[TBL] [Abstract][Full Text] [Related]
13. [Comparision of different interventional therapies for primary liver cancer].
Liu YM; Qin H; Wang CB; Fang XH; Ma QY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
[TBL] [Abstract][Full Text] [Related]
14. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
15. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
Pietrosi G; Miraglia R; Luca A; Vizzini GB; Fili' D; Riccardo V; D'Antoni A; Petridis I; Maruzzelli L; Biondo D; Gridelli B
J Vasc Interv Radiol; 2009 Jul; 20(7):896-902. PubMed ID: 19497762
[TBL] [Abstract][Full Text] [Related]
16. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
[TBL] [Abstract][Full Text] [Related]
17. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
Helmberger T; Dogan S; Straub G; Schrader A; Jüngst C; Reiser M; Waggershauser T; Jakobs T; Hoffmann RT; Löhe F; Graeb C; Rau HG; Schauer R; Jauch KW; Caselmann WH; Göke B; Jüngst D
Digestion; 2007; 75(2-3):104-12. PubMed ID: 17598962
[TBL] [Abstract][Full Text] [Related]
18. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
[TBL] [Abstract][Full Text] [Related]
19. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
20. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]